CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET DYNAMICS
CHAPTER 4 OPHTHALMIC LASERS MARKET, BY TYPE
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PHOTODISRUPTIVE LASERS
4.2.1. Market size and forecast
4.3. SELECTIVE TRABECULOPLASTY LASER (SLT)
4.3.1. Market size and forecast
4.4. PHOTOCOAGULATION LASERS
4.4.1. Market size and forecast
CHAPTER 5 OPHTHALMIC LASERS MARKET, BY PRODUCT
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. FEMTOSECOND LASERS
5.2.1. Market size and forecast
5.3. EXCIMER LASERS
5.3.1. Market size and forecast
5.4. NEODYMIUM-DOPED YTTRIUM ALUMINIUM GARNET (ND:YAG) LASERS,
5.4.1. Market size and forecast
5.5. DIODE LASERS
5.5.1. Market size and forecast
5.6. OTHER LASERS
5.6.1. Market size and forecast
CHAPTER 6 OPHTHALMIC LASERS MARKET, BY APPLICATION
6.1. OVERVIEW
6.1.1. Market size and forecast
6.2. REFRACTIVE ERROR
6.2.1. Market size and forecast
6.3. CATARACT SURGERY
6.3.1. Market size and forecast
6.4. GLAUCOMA SURGERY
6.4.1. Market size and forecast
6.5. OTHERS
6.5.1. Market size and forecast
CHAPTER 7 OPHTHALMIC LASERS MARKET, BY END USER
7.1. OVERVIEW
7.1.1. Market size and forecast
7.2. HOSPITALS
7.2.1. Market size and forecast
7.3. AMBULATORY SERVICE CENTRES
7.3.1. Market size and forecast
7.4. EYE CLINICS
7.4.1. Market size and forecast
CHAPTER 8 OPHTHALMIC LASERS MARKET, BY GEOGRAPHY
8.1. OVERVIEW
8.1.1. Market size and forecast
8.2. NORTH AMERICA
8.2.1. Key market trends
8.2.2. Key growth factors and opportunity
8.2.3. Market size and forecast
8.2.4. U.S. Market size and forecast
8.2.5. Canada Market size and forecast
8.2.6. Mexico Market size and forecast
8.3. EUROPE
8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. France Market size and forecast
8.3.5. Germany Market size and forecast
8.3.6. UK Market size and forecast
8.3.7. Italy Market size and forecast
8.3.8. Spain Market size and forecast
8.3.9. The Netherlands Market size and forecast
8.3.10. Norway Market size and forecast
8.3.11. Russia Market size and forecast
8.3.12. Sweden Market size and forecast
8.3.13. Switzerland Market size and forecast
8.3.14. Rest of Europe Market size and forecast
8.4. ASIA-PACIFIC
8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan Market size and forecast
8.4.5. China Market size and forecast
8.4.6. India Market size and forecast
8.4.7. Australia Market size and forecast
8.4.8. South Korea Market size and forecast
8.4.9. New Zealand Market size and forecast
8.4.10. Taiwan Market size and forecast
8.4.11. Thailand Market size and forecast
8.4.12. Rest of Asia-Pacific Market size and forecast
8.5. LAMEA
8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Brazil Market size and forecast
8.5.5. Saudi Arabia Market size and forecast
8.5.6. South Africa Market size and forecast
8.5.7. Chile Market size and forecast
8.5.8. Columbia Market size and forecast
8.5.9. Egypt Market size and forecast
8.5.10. Iran Market size and forecast
8.5.11. Israel Market size and forecast
8.5.12. Turkey Market size and forecast
8.5.13. Venezuela Market size and forecast
8.5.14. Rest of LAMEA Market size and forecast
CHAPTER 9 COMPANY PROFILES
9.1. CARL ZIESS MEDITEC AG
9.1.1. Company overview
9.1.2. Company snapshot
9.1.3. Operating business segments
9.1.4. Business performance
9.1.5. Key strategic moves and developments
9.2. NOVARTIS AG
9.2.1. Company overview
9.2.2. Company snapshot
9.2.3. Operating business segments
9.2.4. Business performance
9.2.5. Key strategic moves and developments
9.3. TOPCON CORPORATION
9.3.1. Company overview
9.3.2. Company snapshot
9.3.3. Operating business segments
9.3.4. Business performance
9.3.5. Key strategic moves and developments
9.4. ELLEX MEDICAL CORPORATION
9.4.1. Company overview
9.4.2. Company snapshot
9.4.3. Operating business segments
9.4.4. Business performance
9.4.5. Key strategic moves and developments
9.5. QUANTEL INC.
9.5.1. Company overview
9.5.2. Company snapshot
9.5.3. Operating business segments
9.5.4. Business performance
9.5.5. Key strategic moves and developments
9.6. IRIDEX CORPORATION
9.6.1. Company overview
9.6.2. Company snapshot
9.6.3. Operating business segments
9.6.4. Business performance
9.6.5. Key strategic moves and developments
9.7. NIDEK CO., LTD.
9.7.1. Company overview
9.7.2. Company snapshot
9.7.3. Operating business segments
9.7.4. Business performance
9.7.5. Key strategic moves and developments
9.8. LUMENIS
9.8.1. Company overview
9.8.2. Company snapshot
9.8.3. Operating business segments
9.8.4. Business performance
9.8.5. Key strategic moves and developments
9.9. ABBOTT LABORATORIES
9.9.1. Company overview
9.9.2. Company snapshot
9.9.3. Operating business segments
9.9.4. Business performance
9.9.5. Key strategic moves and developments
9.10. ZIEMER OPHTHALMIC SYSTEMS
9.10.1. Company overview
9.10.2. Company snapshot
9.10.3. Operating business segments
9.10.4. Business performance
9.10.5. Key strategic moves and developments